The Lancet Oncology, Early Online Publication, 12 November 2010 doi:10.1016/S1470-2045(10)70256-4 Fang-Hui Zhao MD a *, Margaret Jane Lin BS b *, Feng Chen BSc a, Shang-Ying Hu MD a, Rong Zhang MD a, Jerome L Belinson MD c, Prof John W Sellors MD d, Silvia Franceschi MD e, Prof You-Lin Qiao PhD a , Philip […]
Merck announces FDA Advisory Committee approval of GARDASIL for anal cancer and AIN treatment
The Medical News November 18, 2010 Merck announced today that the U.S. Food and Drug Administration’s (FDA) Vaccines and Related Biological Products Advisory Committee has advised that the data presented support an indication for GARDASIL® [Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) Vaccine, Recombinant] for the prevention of anal cancer and anal intraepithelial […]
HPV shot dilemma: Should gay boys be targeted?
MSNBC.com If you thought the controversy over giving the HPV vaccine to girls was heated, just wait for the fight about the boys. A government health panel is expected to vote soon on whether to recommend vaccinating boys and young men against the human papillomavirus. Since 2006, the vaccine has been advised in girls and […]
Adverse reactions to cancer vaccine reported
Irish Times November 15, 2010 EITHNE DONNELLAN, Health Correspondent MORE THAN 60 adverse reactions to the cervical cancer vaccine used in the State’s national immunisation programme have been reported so far to the Irish Medicines Board (IMB). To date about 45,000 doses of the HPV vaccine have been given to school girls as part of […]
Update on National Monitoring Experience with Gardasil
IRISH MEDICINES BOARD 11th November 2010 The HSE human papillomavirus (HPV) Schools Immunisation Programme commenced in May 2010. It is estimated that 60,000 doses of Gardasil have been distributed and approximately 45,000 doses have been administered up to the end of October 2010. The Irish Medicines Board (IMB) has received a total of 64 reports […]
- « Previous Page
- 1
- …
- 185
- 186
- 187
- 188
- 189
- …
- 199
- Next Page »